| abstract |
The present invention relates to autologous topical formulations containing a controlled medium obtained from the culture of autologous fibroblasts. Unlike other topical formulations, it is autologous because it is derived from cells obtained only by the person using the formulation. This prevents any possible reaction with the protein derived from the cells. Preferred formulations include gels, creams, lotions, and ointments. Topical formulations of controlled media obtained by culturing autologous dermal fibroblasts are topically administered to individuals for the prevention and treatment of scars, the reduction of signs of aging and the improvement of skin quality. |